SCHEMBL4015477

SCHEMBL4015477

CN(C(=O)O)S(=O)(=O)c1cccc(C#CCBr)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 2/20 0.45
HSD11B1 P28845 1/20 0.42
HAO1 Q9UJM8 1/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 2/20 0.37
LMNA P02545 1/20 0.37
RAB9A P51151 3/20 0.37
NPC1 O15118 2/20 0.37
TP53 P04637 1/20 0.37
TNF P01375 1/20 0.37
NOD1 Q9Y239 1/20 0.37
GAA P10253 1/20 0.36
MCOLN3 Q8TDD5 1/20 0.36
PTGER2 P43116 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4011688 0.88 PTGDR2 (0.43) PTGDR2HSD11B1HAO1MEN1KMT2A
SCHEMBL4009251 0.83 HSD11B1 (0.43) HSD11B1CA12CA2CA9SMN1; SMN2
SCHEMBL1858017 0.83 PTGDR2 (0.41) PTGDR2HSD11B1HAO1MEN1KMT2A
SCHEMBL4008265 0.82 LMNA (0.41) PTGDR2HAO1MEN1KMT2ACA12
SCHEMBL3466973 0.81 CA12 (0.42) PTGDR2KMT2ACA12CA1CA2
SCHEMBL4007168 0.77 PTGDR2 (0.43) PTGDR2MEN1KMT2ACA12CA1
SCHEMBL1856320 0.76 STAT5B (0.42) PTGDR2HSD11B1MEN1KMT2ASMN1; SMN2
SCHEMBL1856318 0.76 PTGDR2 (0.36) PTGDR2HSD11B1HAO1MEN1KMT2A
SCHEMBL1855707 0.75 F2 (0.40) PTGDR2HAO1KMT2ACA12CA1
SCHEMBL1863734 0.74 HSD11B1 (0.47) HSD11B1MEN1KMT2ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009080722-A2 CARBOXYLIC DERIVATIVES FOR USE IN THE TREATMENT OF CANCER CRYSTAX PHARMACEUTICALS, S.L. (ES) 2009-07-02 WO disclosed